Stockreport

TransCode Therapeutics, Inc. Announces $8 Million Private Placement

TransCode Therapeutics, Inc.  (RNAZ) 
PDF BOSTON, Nov. 27, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ), the RNA Oncology Company™ committed to more effectively treating cancer using RN [Read more]